327 related articles for article (PubMed ID: 27026367)
1. Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.
Garsen M; Lenoir O; Rops AL; Dijkman HB; Willemsen B; van Kuppevelt TH; Rabelink TJ; Berden JH; Tharaux PL; van der Vlag J
J Am Soc Nephrol; 2016 Dec; 27(12):3545-3551. PubMed ID: 27026367
[TBL] [Abstract][Full Text] [Related]
2. The role of heparanase and the endothelial glycocalyx in the development of proteinuria.
Garsen M; Rops AL; Rabelink TJ; Berden JH; van der Vlag J
Nephrol Dial Transplant; 2014 Jan; 29(1):49-55. PubMed ID: 24166469
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.
Garsen M; Sonneveld R; Rops AL; Huntink S; van Kuppevelt TH; Rabelink TJ; Hoenderop JG; Berden JH; Nijenhuis T; van der Vlag J
J Pathol; 2015 Dec; 237(4):472-81. PubMed ID: 26202309
[TBL] [Abstract][Full Text] [Related]
4. Heparanase in Kidney Disease.
van der Vlag J; Buijsers B
Adv Exp Med Biol; 2020; 1221():647-667. PubMed ID: 32274730
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
[TBL] [Abstract][Full Text] [Related]
6. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
[TBL] [Abstract][Full Text] [Related]
7. The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway.
An X; Zhang L; Yao Q; Li L; Wang B; Zhang J; He M; Zhang J
Mol Cell Endocrinol; 2018 Jul; 470():14-25. PubMed ID: 28478303
[TBL] [Abstract][Full Text] [Related]
8. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.
Ortmann J; Amann K; Brandes RP; Kretzler M; Münter K; Parekh N; Traupe T; Lange M; Lattmann T; Barton M
Hypertension; 2004 Dec; 44(6):974-81. PubMed ID: 15545511
[TBL] [Abstract][Full Text] [Related]
9. Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy.
Boels MGS; Koudijs A; Avramut MC; Sol WMPJ; Wang G; van Oeveren-Rietdijk AM; van Zonneveld AJ; de Boer HC; van der Vlag J; van Kooten C; Eulberg D; van den Berg BM; IJpelaar DHT; Rabelink TJ
Am J Pathol; 2017 Nov; 187(11):2430-2440. PubMed ID: 28837800
[TBL] [Abstract][Full Text] [Related]
10. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy.
Boels MG; Avramut MC; Koudijs A; Dane MJ; Lee DH; van der Vlag J; Koster AJ; van Zonneveld AJ; van Faassen E; Gröne HJ; van den Berg BM; Rabelink TJ
Diabetes; 2016 Aug; 65(8):2429-39. PubMed ID: 27207530
[TBL] [Abstract][Full Text] [Related]
11. Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes.
Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR
Cardiovasc Diabetol; 2024 Feb; 23(1):50. PubMed ID: 38302978
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect on podocyte number in experimental diabetic nephropathy resulting from combined atrasentan and RAAS inhibition therapy.
Hudkins KL; Wietecha TA; Steegh F; Alpers CE
Am J Physiol Renal Physiol; 2020 May; 318(5):F1295-F1305. PubMed ID: 32249614
[TBL] [Abstract][Full Text] [Related]
13. Heparanase is essential for the development of diabetic nephropathy in mice.
Gil N; Goldberg R; Neuman T; Garsen M; Zcharia E; Rubinstein AM; van Kuppevelt T; Meirovitz A; Pisano C; Li JP; van der Vlag J; Vlodavsky I; Elkin M
Diabetes; 2012 Jan; 61(1):208-16. PubMed ID: 22106160
[TBL] [Abstract][Full Text] [Related]
14. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.
Singh A; Satchell SC; Neal CR; McKenzie EA; Tooke JE; Mathieson PW
J Am Soc Nephrol; 2007 Nov; 18(11):2885-93. PubMed ID: 17942961
[TBL] [Abstract][Full Text] [Related]
15. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
Yoshibayashi M; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Asanuma K; Maegawa H; Araki SI
Biochem Biophys Res Commun; 2020 Apr; 525(2):319-325. PubMed ID: 32089264
[TBL] [Abstract][Full Text] [Related]
16. Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis.
Garsen M; Benner M; Dijkman HB; van Kuppevelt TH; Li JP; Rabelink TJ; Vlodavsky I; Berden JH; Rops AL; Elkin M; van der Vlag J
Am J Pathol; 2016 Apr; 186(4):805-15. PubMed ID: 26873445
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
[TBL] [Abstract][Full Text] [Related]
18. Reduction of anionic sites in the glomerular basement membrane by heparanase does not lead to proteinuria.
van den Hoven MJ; Wijnhoven TJ; Li JP; Zcharia E; Dijkman HB; Wismans RG; Rops AL; Lensen JF; van den Heuvel LP; van Kuppevelt TH; Vlodavsky I; Berden JH; van der Vlag J
Kidney Int; 2008 Feb; 73(3):278-87. PubMed ID: 18046314
[TBL] [Abstract][Full Text] [Related]
19. Heparanase-driven inflammation from the AGEs-stimulated macrophages changes the functions of glomerular endothelial cells.
Xu G; Qin Q; Yang M; Qiao Z; Gu Y; Niu J
Diabetes Res Clin Pract; 2017 Feb; 124():30-40. PubMed ID: 28081450
[TBL] [Abstract][Full Text] [Related]
20. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
